1. European & Developing Countries Clinical Trials Partnership (EDCTP)
Dr Ole Olesen | Director of North-North Cooperation

2. EDCTP funding streams (simplified)
Open calls-for-proposals
(around a dedicated topic)
Clinical Trials in sub-Saharan Africa (85%)
Collaborations between research teams in Europe and Africa (and elsewhere)
Capacity building activities (15%)
Fellowships, networking, regulatory, ethics

3. EDCTP2 project portfolio by intervention
€4.1 M
14 grants
( )
€24.4 M
18 grants
Fellowships
€12.2 M
47 grants
€217.8 M
34 grants
€258.5 M
113 grants
Vaccines
€82.7 M
9 grants
Diagnostics
€30.9 M
10 grants
Clinical Management
€36.3 M
4 grants
Drugs
€67.9 M
11 grants
*including treatment and prevention.
***cross-cutting activities including regional networks of excellence

4. Clinical trials by disease
Intervention type by disease for clinical trials projects
66 M
34.4 M

5. THANK YOU

6. TB projects in EDCTP2: first 3 years
Acronym
Study topic
Coordinator
Country
No. participants
EDCTP grant
StopTB/HIV at one
Diagnostics
Liverpool School of Tropical Medicine (LSTM)
United Kingdom 5
€1,413,749
Screen TB
Stellenbosch University
South Africa 9
€2,995,574
DIAMA*
Centre National Hospitalier de Pneumo-Phtisiologie
Benin 13
€2,967,203
Predict TB
€7,722,491
RaPaed TB
Ludwig-Maximilians-Universitaet Muenchen (LMU)
Germany 10
€2,999,644
PanACEA
Drugs
Stichting Katholieke Universiteit- Radboudumc (RUMC)
Netherlands 16
€11,394,775
VirTUAL
University of Liverpool 6
€2,058,003
POR TB consortium
Vaccines
Statens Serum Institut (SSI)
Denmark 7
€13,788,161
MTBVAC - Newborns
Biofabri S.L.
Spain
€5,537,093
priMe
Vakzine Projekt Management GmbH 14
€12,493,179
POI-TB
Aeras Global Tuberculosis Foundation NPC
€2,575,019
€65,944,891